Pharmaceuticals stories - Page 2

OpenText has launched the AI Data Platform to securely unify and manage enterprise data, enhancing AI accuracy and integration across industries.

Dashmote has raised $6 million to launch DashSalesAI, an AI agent boosting efficiency for field sales teams via mobile platforms like WhatsApp.

XYZ Reality has renewed its ISO 27001 certification, underscoring its commitment to data security in sectors like defence, energy and pharmaceuticals.

Nebius has awarded over $850,000 in GPU credits to four AI health startups advancing cancer prediction, drug discovery, genomics and diagnostics.

Ransomware attacks on industrial firms surged to 708 in Q1 2025, led by manufacturing, with North America and Europe hardest hit, warns Dragos report.

AI adoption is crucial for businesses to thrive, not just survive, amid fears of job losses; embracing AI boosts productivity and job evolution.

FourKites and Chorus partner to enhance supply chain visibility and inventory management with AI-powered digital twins launching in Q2 2025.

Hurdle uses an AI platform to speed up diagnostics development, tackling inefficiencies and enabling quicker, scalable precision medicine solutions.

Toronto AI firm Skinopathy launches GetSkinHelp app, enabling Canadians to screen for skin cancer from home and access timely medical care.

Australia's pharmaceutical industry is tackling complex logistics challenges, ensuring temperature-sensitive medications remain effective amid rising demand.

NVIDIA and Google's Alphabet have announced a significant collaboration to enhance AI accessibility in sectors like healthcare and energy, integrating cutting-edge technologies.

Scimplify has secured USD $40 million in Series B funding, boosting its total to USD $54 million, to enhance its specialty chemicals platform and expand internationally.

SECQAI has unveiled the world's first hybrid Quantum Large Language Model, promising to revolutionise AI by harnessing quantum computing for enhanced efficiency.

Nymi has unveiled the Nymi Band 4, a versatile wearable authenticator designed for handsfree passwordless Multi-Factor Authentication in diverse operational environments.

The peptide Active Pharmaceutical Ingredient market is poised for significant growth, driven by demand for targeted therapies and advances in synthesis technology.

IFS has signed an agreement to acquire Copperleaf Technologies, aiming to finalise by Q3 2024. The move enhances IFS's AI-driven asset management capabilities.